Moderna seeks FDA authorisation for fourth COVID-19 jab for adults
March 18, 2022Medical Communications
Moderna has requested an EUA from the FDA for a fourth dose of its COVID-19 vaccine, as a booster for …
NIH fund research for Short Bowel Syndrome
March 18, 2022Medical Communications
A Saint Louis University School of Medicine physician-scientist has received funding of $428,020, from the National Institutes of Allergy and …
GSK halts new clinical trials in Russia
March 18, 2022Medical Communications
Britain’s second biggest drugmaker, GlaxoSmithKline (GSK), has joined other pharmaceutical companies including Pfizer, sharing that it will not start clinical …
AstraZeneca could abandon US regulatory efforts for COVID-19 vaccine
March 18, 2022Medical Communications
The Oxford/AstraZeneca vaccine has not yet been approved in the US, and has not been submitted for Emergency Use Authorisation …
Global COVID-19 cases up for first time in weeks
March 17, 2022Business Services
After more than a month of decline, global cases of COVID-19 have increased. WHO have stated that cases of the …
War in Ukraine could worsen COVID-19 pandemic, says WHO
March 17, 2022Business Services
WHO has expressed concern that the war in Ukraine could worsen the COVID-19 pandemic, and it is aiming to do …
Ukraine: Health facilities a “target” of war
March 17, 2022Business Services
Healthcare facilities have become a “target” of war, WHO has said, warning that the health system in Ukraine is “teetering …
Targeted drug Olaparib improves survival in early-stage breast cancer
March 17, 2022Business Services
The Institute of Cancer Research (ICR), London, has reported new findings that the targeted drug olaparib improves survival in women …
Shaping the new frontiers of women’s health
March 16, 2022March 8 was International Women’s Day and provided a perfect opportunity for Pharmafocus to dive deep into women’s health. Lina …
Sanofi and Seagen collaborate to develop novel antibody-drug conjugates
March 16, 2022Research and Development
Sanofi and Seagen announced an exclusive collaboration agreement to design, develop, and commercialise antibody-drug conjugates (ADCs) for up to three …
NICE guidance for treating relapsed and refractory multiple myeloma
March 16, 2022Research and Development
NICE has published guidance from the new cancer drug, daratumumab, for the treatment of relapsed and refractory myeloma. Around 350 …
FDA approves Symbicort to treat asthma and COPD
March 16, 2022Research and Development
The FDA has approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, for the treatment of …
FDA clearance for clinical surveillance solution
March 16, 2022Research and Development
The latest Philips Capsule Surveillance solution has received market clearance from the FDA, paving the way for widespread deployment across …
Sanofi and Blackstone Life Science collaborate to advance multiple myeloma treatment
March 15, 2022Manufacturing and Production
Sanofi and Blackstone announced a strategic, risk-sharing €300 million collaboration, to advance innovative treatment for multiple myeloma. This funding will …
Grifols XEMBIFY receives European approvals
March 15, 2022Manufacturing and Production
Grifols has announced that XEMBIFY, its innovative 20% subcutaneous immunoglobulin (SCIG), has been approved by several European Union member state …
Groundbreaking comprehensive genomic profiling test for cancer
March 15, 2022Manufacturing and Production
Illumia have announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumour genes and …
Almirall announces collaboration with University of Michigan
March 15, 2022Manufacturing and Production
Almirall has announced a collaboration agreement with the University of Michigan to accelerate the understanding of the factors that trigger …
CanSinoBIO’s Convidecia effective as booster against Omicron
March 14, 2022Sales and Marketing
According to an academic paper on the efficacy of CanSinoBIO’s recombinant COVID-19 vaccine, published on medRxiv, the vaccine is effective …
UK Health Secretary: rise in COVID-19 cases ‘expected’
March 14, 2022Sales and Marketing
A surge in COVID-19 cases was to be “expected”, following the ease of pandemic restrictions in England, insisted UK Health …
First and only approved medicine in US targeting BRCA mutations in early breast cancer
March 14, 2022Sales and Marketing
LYNPARZA® (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative high-risk …
